Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, nonmelanomatous (squamous and basal cell)
Stage/Subtype:  basal cell carcinoma of the skin
Country:  U.S.A.
Trial Type:  Treatment
Results 1-8 of 8 for your search:
Start Over
Radiation Therapy and Vismodegib in Treating Patients With Locally Advanced Head and Neck Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CC #122011, NCI-2013-00871, 122011, NCT01835626
Photodynamic Therapy and Vismodegib in Treating Patients with Multiple Basal Cell Cancers
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 1511201549, NCI-2016-00096, ML28849, NCT02639117
Pembrolizumab with or without Vismodegib in Treating Skin Basal Cell Cancer That Is Metastatic or Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0031, NCI-2015-01869, 350, NCT02690948
Effectiveness of Narrow Margins in Patients with Low-Risk Basal Cell Carcinoma Undergoing Surgery
Status: Active
Phase: No phase specified
Type: Treatment
Age: Not specified
Trial IDs: 11D.479, NCI-2015-01624, 2011-68, NCT01903239
Itraconazole in Treating Patients with Basal Cell Carcinoma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: J1299, NCI-2014-01255, NA_00077461, NCT02120677
Electronic Skin Surface Brachytherapy in Treating Older Patients with Newly Diagnosed Early Stage Basal Cell or Squamous Cell Skin Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 60 and over
Trial IDs: 14-001, NCI-2014-01090, NCT02131805
Sonidegib and Buparlisib in Treating Patients with Advanced or Metastatic Basal Cell Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0020, NCI-2014-02200, 5136, NCT02303041
Topical Itraconazole in Treating Patients with Basal Cell Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SKIN0030, NCI-2016-00452, NCT02735356
Start Over